Ron Sugar

(Dr. Ronald Sugar Ph.D.)

Currently holds positions in Uber Technologies Inc, Amgen Inc, Apple Inc and Chevron Corp

Positions

Position Company Period
Independent Chairperson of the Board Uber Technologies Inc July 1, 2018 -
Independent Director Amgen Inc July 22, 2010 -
Independent Director Apple Inc Nov. 17, 2010 -
Lead Independent Director Chevron Corp Jan. 1, 2015 -
Independent Director Air Lease Corp April 1, 2010 - May 1, 2020
Independent Director Chevron Corp April 27, 2005 - Jan. 1, 2015
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-05-12 2021-05-12
US Amgen Inc (AMGN)
PS Planned sale
1,000 -5.9%
250.59
USD 250,590 		1,000 -5.9% 250.59 USD 250,590
2021-04-15 2021-04-14
US Amgen Inc (AMGN)
PS Planned sale
1,000 -5.9%
249.98
USD 249,980 		1,000 -5.9% 249.98 USD 249,980
2021-03-10 2021-03-10
US Amgen Inc (AMGN)
PS Planned sale
1,000 -6.0%
231.53
USD 231,530 		1,000 -6.0% 231.53 USD 231,530
2021-02-10 2021-02-10
US Amgen Inc (AMGN)
PS Planned sale
1,000 -6.0%
238.40
USD 238,400 		1,000 -6.0% 238.40 USD 238,400
2021-01-14 2021-01-13
US Amgen Inc (AMGN)
PS Planned sale
1,000 -6.0%
235.99
USD 235,990 		1,000 -6.0% 235.99 USD 235,990
2020-08-19 2020-08-19
US Amgen Inc (AMGN)
PS Planned sale
1,000 -6.0%
241.02
USD 241,020 		1,000 -6.0% 241.02 USD 241,020
2020-07-22 2020-07-22
US Amgen Inc (AMGN)
PS Planned sale
1,000 -6.0%
259.79
USD 259,790 		1,000 -6.0% 259.79 USD 259,790
2020-06-17 2020-06-17
US Amgen Inc (AMGN)
PS Planned sale
1,000 -6.0%
228.54
USD 228,540 		1,000 -6.0% 228.54 USD 228,540
2020-05-20 2020-05-20
US Amgen Inc (AMGN)
PS Planned sale
1,000 -6.1%
229.27
USD 229,270 		1,000 -6.1% 229.27 USD 229,270
2020-04-22 2020-04-22
US Amgen Inc (AMGN)
PS Planned sale
1,000 -6.4%
233.35
USD 233,350 		1,000 -6.4% 233.35 USD 233,350
2019-11-07 2019-11-06
US Amgen Inc (AMGN)
PS Planned sale
2,000 -12.2%
215.45
USD 430,900 		2,000 -12.2% 215.45 USD 430,900
2019-10-03 2019-10-02
US Amgen Inc (AMGN)
PS Planned sale
2,000 -12.2%
193.58
USD 387,160 		2,000 -12.2% 193.58 USD 387,160
2019-09-04 2019-09-04
US Amgen Inc (AMGN)
PS Planned sale
2,000 -12.2%
206.70
USD 413,400 		2,000 -12.2% 206.70 USD 413,400
2019-08-08 2019-08-07
US Amgen Inc (AMGN)
PS Planned sale
2,000 -12.2%
183.04
USD 366,080 		2,000 -12.2% 183.04 USD 366,080
2019-07-08 2019-07-03
US Amgen Inc (AMGN)
PS Planned sale
2,000 -12.2%
187.58
USD 375,160 		2,000 -12.2% 187.58 USD 375,160
2019-06-05 2019-06-05
US Amgen Inc (AMGN)
PS Planned sale
2,000 -12.3%
175.68
USD 351,360 		2,000 -12.3% 175.68 USD 351,360
2019-05-03 2019-05-01
US Amgen Inc (AMGN)
PS Planned sale
2,000 -13.3%
175.73
USD 351,460 		2,000 -13.3% 175.73 USD 351,460
2019-04-03 2019-04-03
US Amgen Inc (AMGN)
PS Planned sale
2,000 -13.3%
193.18
USD 386,360 		2,000 -13.3% 193.18 USD 386,360
2019-03-08 2019-03-06
US Amgen Inc (AMGN)
PS Planned sale
2,000 -13.3%
188.88
USD 377,760 		2,000 -13.3% 188.88 USD 377,760
2019-02-11 2019-02-07
US Amgen Inc (AMGN)
PS Planned sale
2,000 -13.3%
190.00
USD 380,000 		2,000 -13.3% 190.00 USD 380,000
// ... existing code ... // ... rest of the file ...